<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37715857</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>31</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1970-9366</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Internal and emergency medicine</Title><ISOAbbreviation>Intern Emerg Med</ISOAbbreviation></Journal><ArticleTitle>Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective study.</ArticleTitle><Pagination><StartPage>183</StartPage><EndPage>190</EndPage><MedlinePgn>183-190</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11739-023-03400-x</ELocationID><Abstract><AbstractText>Short- and medium-term cardio-pulmonary sequelae after COVID-19 have been extensively studied. However, studies with longer follow-ups are required. This study aims to identify and characterise cardio-pulmonary sequelae, in patients hospitalised for SARS-CoV-2 pneumonia, at 24&#xa0;months follow-up. This is a prospective, observational cohort study conducted on consecutive patients hospitalised for COVID-19 and acute respiratory failure. Patients were followed up at 24&#xa0;months with complete pulmonary function tests (PFTs), 6-min walking test and a dyspnoea score (Modified Medical Research Council scale). A subgroup of patients with at least one clinical or functional sign suggestive of increased pulmonary pressures also underwent transthoracic echocardiography (TTE) to evaluate the presence of direct or indirect signs of pulmonary hypertension (PH). Ninety consecutive patients (74% men, median age 59.1&#xa0;years) were enrolled in the study. In regard to PFTs, carbon monoxide diffusion capacity (DLCO) impairment was observed in 23 cases (26%), in all cases of mild entity. When considering the dyspnoea, 30 (34%) patients showed some degree of breathlessness. Forty patients underwent TTE. No patients had overt PH or chronic thromboembolic PH. However, all patients showed a hyperdynamic state of the right ventricle, and 8 (20%) patients had a decreased acceleration time on pulmonary valve, signs of increased pulmonary vasculature resistances and afterload elevation. At 24-month follow-up after severe COVID-19, DLCO and TTE prove to be the most sensitive tool to detect cardio-pulmonary sequelae. Dyspnoea is still present in about one-third of patients and requires a multidisciplinary approach.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Faverio</LastName><ForeName>Paola</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-0360-1237</Identifier><AffiliationInfo><Affiliation>UOC Pneumologia, Respiratory Unit, Fondazione IRCCS San Gerardo dei Tintori, Via Pergolesi 33, 20900, Monza, Italy. paola.faverio@unimib.it.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine and Surgery, University of Milano Bicocca, Milan, Italy. paola.faverio@unimib.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paciocco</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>UOC Pneumologia, Respiratory Unit, Fondazione IRCCS San Gerardo dei Tintori, Via Pergolesi 33, 20900, Monza, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine and Surgery, University of Milano Bicocca, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tassistro</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Bicocca Center of Bioinformatics, Biostatistics and Bioimaging, University of Milano Bicocca, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rebora</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Bicocca Center of Bioinformatics, Biostatistics and Bioimaging, University of Milano Bicocca, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rossi</LastName><ForeName>Emanuela</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Bicocca Center of Bioinformatics, Biostatistics and Bioimaging, University of Milano Bicocca, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monzani</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>UOC Pneumologia, Respiratory Unit, Fondazione IRCCS San Gerardo dei Tintori, Via Pergolesi 33, 20900, Monza, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine and Surgery, University of Milano Bicocca, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tundo</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>UOC Pneumologia, Respiratory Unit, Fondazione IRCCS San Gerardo dei Tintori, Via Pergolesi 33, 20900, Monza, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine and Surgery, University of Milano Bicocca, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Milano</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>UOC Pneumologia, Respiratory Unit, Fondazione IRCCS San Gerardo dei Tintori, Via Pergolesi 33, 20900, Monza, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine and Surgery, University of Milano Bicocca, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Messa</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>UOC Pneumologia, Respiratory Unit, Fondazione IRCCS San Gerardo dei Tintori, Via Pergolesi 33, 20900, Monza, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine and Surgery, University of Milano Bicocca, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marocchi</LastName><ForeName>Raffaele</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>UOC Pneumologia, Respiratory Unit, Fondazione IRCCS San Gerardo dei Tintori, Via Pergolesi 33, 20900, Monza, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine and Surgery, University of Milano Bicocca, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pesci</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>UOC Pneumologia, Respiratory Unit, Fondazione IRCCS San Gerardo dei Tintori, Via Pergolesi 33, 20900, Monza, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine and Surgery, University of Milano Bicocca, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Foti</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>School of Medicine and Surgery, Anesthesia and Intensive Care Unit, University of Milano Bicocca, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Squillace</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Infectious Disease Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cogliandro</LastName><ForeName>Viola</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Infectious Disease Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lettino</LastName><ForeName>Maddalena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardio-Thoracic and Vascular Department, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strepparava</LastName><ForeName>Maria Grazia</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Clinical Psychology Unit, School of Medicine and Surgery, University of Milano Bicocca, Monza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellelli</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>School of Medicine and Surgery, Acute Geriatric Unit, University of Milano Bicocca, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrarese</LastName><ForeName>Carlo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>School of Medicine and Surgery, Neurology Unit, University of Milano Bicocca, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valsecchi</LastName><ForeName>Maria Grazia</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Bicocca Center of Bioinformatics, Biostatistics and Bioimaging, University of Milano Bicocca, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonfanti</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>School of Medicine and Surgery, University of Milano Bicocca, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Disease Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luppi</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>UOC Pneumologia, Respiratory Unit, Fondazione IRCCS San Gerardo dei Tintori, Via Pergolesi 33, 20900, Monza, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine and Surgery, University of Milano Bicocca, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>STORM Long-COVID Team</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Intern Emerg Med</MedlineTA><NlmUniqueID>101263418</NlmUniqueID><ISSNLinking>1828-0447</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006976" MajorTopicYN="Y">Hypertension, Pulmonary</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Pneumonia</Keyword><Keyword MajorTopicYN="N">Pulmonary circulation</Keyword><Keyword MajorTopicYN="N">Pulmonary hypertension</Keyword><Keyword MajorTopicYN="N">Respiratory function tests</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Pollastri</LastName><ForeName>Ester</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Caramma</LastName><ForeName>Ilaria</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cappelletti</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bonaffini</LastName><ForeName>Luca</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Valagussa</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Salvarani</LastName><ForeName>Valerio</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pozzi</LastName><ForeName>Matteo</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Beretta</LastName><ForeName>Simone</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mori</LastName><ForeName>Silvia</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rossi</LastName><ForeName>Emanuela</ForeName><Initials>E</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>31</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>16</Day><Hour>20</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>16</Day><Hour>11</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37715857</ArticleId><ArticleId IdType="pmc">PMC10827839</ArticleId><ArticleId IdType="doi">10.1007/s11739-023-03400-x</ArticleId><ArticleId IdType="pii">10.1007/s11739-023-03400-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lee JH, Yim JJ, et al. Pulmonary function and chest computed tomography abnormalities 6&#x2013;12 months after recovery from COVID-19: a systematic review and meta-analysis. Respir Res. 2022;23(1):233. doi: 10.1186/s12931-022-02163-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-022-02163-x</ArticleId><ArticleId IdType="pmc">PMC9446643</ArticleId><ArticleId IdType="pubmed">36068582</ArticleId></ArticleIdList></Reference><Reference><Citation>Faverio P, Luppi F, et al. One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study. Respir Res. 2022;23(1):65. doi: 10.1186/s12931-022-01994-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-022-01994-y</ArticleId><ArticleId IdType="pmc">PMC8934910</ArticleId><ArticleId IdType="pubmed">35313890</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaramuzzo G, Ronzoni L, et al. Long-term dyspnea, regional ventilation distribution and peripheral lung function in COVID-19 survivors: a 1 year follow up study. BMC Pulm Med. 2022;22(1):408. doi: 10.1186/s12890-022-02214-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12890-022-02214-5</ArticleId><ArticleId IdType="pmc">PMC9643983</ArticleId><ArticleId IdType="pubmed">36352423</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, Liu X, et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respir Med. 2021;9(7):747&#x2013;754. doi: 10.1016/S2213-2600(21)00174-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00174-0</ArticleId><ArticleId IdType="pmc">PMC8099316</ArticleId><ArticleId IdType="pubmed">33964245</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkodaymi MS, Omrani OA, et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin Microbiol Infect. 2022;28(5):657&#x2013;666. doi: 10.1016/j.cmi.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8812092</ArticleId><ArticleId IdType="pubmed">35124265</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamberini L, Mazzoli CA, et al. Health-related quality of life profiles, trajectories, persistent symptoms and pulmonary function one year after ICU discharge in invasively ventilated COVID-19 patients, a prospective follow-up study. Respir Med. 2021;189:106665. doi: 10.1016/j.rmed.2021.106665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2021.106665</ArticleId><ArticleId IdType="pmc">PMC8531241</ArticleId><ArticleId IdType="pubmed">34717097</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai J, Lin K, et al. A one-year follow-up study of systematic impact of long COVID symptoms among patients post SARS-CoV-2 omicron variants infection in Shanghai. China Emerg Microbes Infect. 2023;5:2220578. doi: 10.1080/22221751.2023.2220578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2023.2220578</ArticleId><ArticleId IdType="pmc">PMC10281439</ArticleId><ArticleId IdType="pubmed">37272336</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogun H, G&#xfc;l M, et al. One-year follow-up evaluation of radiological and respiratory findings and functional capacity in COVID-19 survivors without comorbidities. Medicine (Baltimore) 2023;102(22):e33960. doi: 10.1097/MD.0000000000033960.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000033960</ArticleId><ArticleId IdType="pmc">PMC10237308</ArticleId><ArticleId IdType="pubmed">37266609</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballouz T, Menges D, et al. Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study. BMJ. 2023;31(381):e074425. doi: 10.1136/bmj-2022-074425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-074425</ArticleId><ArticleId IdType="pmc">PMC10230608</ArticleId><ArticleId IdType="pubmed">37257891</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X, Chao Hou C, et al. Two-year health outcomes in hospitalized COVID-19 survivors in China. JAMA Netw Open. 2022;5(9):e2231790. doi: 10.1001/jamanetworkopen.2022.31790.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.31790</ArticleId><ArticleId IdType="pmc">PMC9478774</ArticleId><ArticleId IdType="pubmed">36107425</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Li X, et al. Lung-function trajectories in COVID-19 survivors after discharge: a two-year longitudinal cohort study. EClinicalMedicine. 2022;28(54):101668. doi: 10.1016/j.eclinm.2022.101668.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101668</ArticleId><ArticleId IdType="pmc">PMC9514976</ArticleId><ArticleId IdType="pubmed">36188433</ArticleId></ArticleIdList></Reference><Reference><Citation>Faverio P, Luppi F, et al. Six-month pulmonary impairment after severe COVID-19: a prospective, multicentre follow-up study. Respiration. 2021;100(11):1078&#x2013;1087. doi: 10.1159/000518141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000518141</ArticleId><ArticleId IdType="pmc">PMC8450855</ArticleId><ArticleId IdType="pubmed">34515212</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang RM, Badano LP, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. J Am Soc Echocardiogr. 2015;28(1):1&#x2013;39.e14. doi: 10.1016/j.echo.2014.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2014.10.003</ArticleId><ArticleId IdType="pubmed">25559473</ArticleId></ArticleIdList></Reference><Reference><Citation>Humbert M, Kovacs G, et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 2022;43(38):3618&#x2013;3731. doi: 10.1093/eurheartj/ehac237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac237</ArticleId><ArticleId IdType="pubmed">36017548</ArticleId></ArticleIdList></Reference><Reference><Citation>Dammassa V, Corradi F, et al. Pulmonary artery acceleration time accuracy for systolic pulmonary artery pressure estimation in critically ill patients. Ultrasound J. 2022;14(1):26. doi: 10.1186/s13089-022-00276-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13089-022-00276-4</ArticleId><ArticleId IdType="pmc">PMC9209611</ArticleId><ArticleId IdType="pubmed">35723841</ArticleId></ArticleIdList></Reference><Reference><Citation>Granstam SO, Bj&#xf6;rklund E, et al. Use of echocardiographic pulmonary acceleration time and estimated vascular resistance for the evaluation of possible pulmonary hypertension. Cardiovasc Ultrasound. 2013;27(11):7. doi: 10.1186/1476-7120-11-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1476-7120-11-7</ArticleId><ArticleId IdType="pmc">PMC3600025</ArticleId><ArticleId IdType="pubmed">23445525</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsoularis I, Fonseca-Rodr&#xed;guez O, et al. Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study. BMJ. 2022;6(377):e069590. doi: 10.1136/bmj-2021-069590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069590</ArticleId><ArticleId IdType="pmc">PMC8984137</ArticleId><ArticleId IdType="pubmed">35387772</ArticleId></ArticleIdList></Reference><Reference><Citation>Cueto-Robledo G, Roldan-Valadez E, Graniel-Palafox LE, et al. Chronic thromboembolic pulmonary hypertension (CTEPH): a review of another sequel of severe post-covid-19 pneumonia. Curr Probl Cardiol. 2022;25:101187. doi: 10.1016/j.cpcardiol.2022.101187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpcardiol.2022.101187</ArticleId><ArticleId IdType="pmc">PMC8956357</ArticleId><ArticleId IdType="pubmed">35346727</ArticleId></ArticleIdList></Reference><Reference><Citation>Rigolli M, Sivalokanathan S, et al. A hyperdynamic RV is an early marker of clinical decompensation and cardiac recovery in aortic stenosis with normal LV ejection fraction. JACC Cardiovasc Imaging. 2019;12(1):214&#x2013;216. doi: 10.1016/j.jcmg.2018.08.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2018.08.029</ArticleId><ArticleId IdType="pubmed">30448135</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahmy OH, Daas FM, et al. Is microthrombosis the main pathology in coronavirus disease 2019 severity?&#x2014;a systematic review of the postmortem pathologic findings. Crit Care Explor. 2021;3(5):e0427. doi: 10.1097/CCE.0000000000000427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCE.0000000000000427</ArticleId><ArticleId IdType="pmc">PMC8140776</ArticleId><ArticleId IdType="pubmed">34036278</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbarialiabad H, Taghrir MH, et al. Long COVID, a comprehensive systematic scoping review. Infection. 2021;49(6):1163&#x2013;1186. doi: 10.1007/s15010-021-01666-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01666-x</ArticleId><ArticleId IdType="pmc">PMC8317481</ArticleId><ArticleId IdType="pubmed">34319569</ArticleId></ArticleIdList></Reference><Reference><Citation>Rolando LM, Villafa&#xf1;e JH, et al. Multicomponent exercise program to improve the immediate sequelae of COVID-19: a prospective study with a brief report of 2-year follow-up. Int J Environ Res Public Health. 2022;19(19):12396. doi: 10.3390/ijerph191912396.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191912396</ArticleId><ArticleId IdType="pmc">PMC9566039</ArticleId><ArticleId IdType="pubmed">36231696</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue S, Hatakeyama J, et al. Post-intensive care syndrome: its pathophysiology, prevention, and future directions. Acute Med Surg. 2019;6(3):233&#x2013;246. doi: 10.1002/ams2.415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ams2.415</ArticleId><ArticleId IdType="pmc">PMC6603316</ArticleId><ArticleId IdType="pubmed">31304024</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>